GTS Securities’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
GTS Securities's BIIB Position: Q3 2026 in Review
GTS Securities opened a new position in Biogen (BIIB) in Q3 2026: 1,497 shares worth $338K. The stake represents 0.01% of the portfolio and ranks #1160 among its holdings. This is a return to the name: GTS Securities previously reported a position in BIIB as recently as Q1 2026.
GTS Securities first reported a position in BIIB in Q2 2023 and has held it in 9 quarters since. The position peaked at $4.14M in Q4 2023. 1,048 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- GTS Securities held 1,497 shares of Biogen worth $338K as of Q3 2026.
- Biogen was a new GTS Securities position in Q3 2026.
- Biogen made up 0.01% of GTS Securities's portfolio in Q3 2026, its #1160 holding.
- GTS Securities first reported a position in Biogen in Q2 2023 and has held it in 9 quarters since.
- GTS Securities's Biogen position peaked at $4.14M in Q4 2023.
- 1,048 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on GTS Securities's 13F filing for Q3 2026, filed 16 Nov 2026.